Rubenstein JL - Search Results

1

Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.

Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL. Wieduwilt MJ, et al. Among authors: rubenstein jl. Clin Cancer Res. 2012 Feb 15;18(4):1146-55. doi: 10.1158/1078-0432.CCR-11-0625. Epub 2012 Jan 6. Clin Cancer Res. 2012. PMID: 22228634 Free PMC article. Clinical Trial.

2

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption.

Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA. Rubenstein JL, et al. Neoplasia. 2000 Jul-Aug;2(4):306-14. doi: 10.1038/sj.neo.7900102. Neoplasia. 2000. PMID: 11005565 Free PMC article.

3

Hemorrhage and VEGF expression in a case of primary CNS lymphoma.

Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Rubenstein J, et al. J Neurooncol. 2002 May;58(1):53-6. doi: 10.1023/a:1015887312455. J Neurooncol. 2002. PMID: 12160141

4

Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment.

Rubenstein JL, Combs D, Rosenberg J, Levy A, McDermott M, Damon L, Ignoffo R, Aldape K, Shen A, Lee D, Grillo-Lopez A, Shuman MA. Rubenstein JL, et al. Blood. 2003 Jan 15;101(2):466-8. doi: 10.1182/blood-2002-06-1636. Epub 2002 Sep 5. Blood. 2003. PMID: 12393404 Free article.

5

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

Shenkier TN, Blay JY, O'Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O'Brien P, Rubenstein J, Connors JM. Shenkier TN, et al. J Clin Oncol. 2005 Apr 1;23(10):2233-9. doi: 10.1200/JCO.2005.07.109. J Clin Oncol. 2005. PMID: 15800313

6

Pathology and genetics of primary central nervous system and intraocular lymphoma.

Rubenstein JL, Treseler P, O'Brien JM. Rubenstein JL, et al. Hematol Oncol Clin North Am. 2005 Aug;19(4):705-17, vii. doi: 10.1016/j.hoc.2005.05.012. Hematol Oncol Clin North Am. 2005. PMID: 16083831 Review.

7

Gene expression and angiotropism in primary CNS lymphoma.

Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M. Rubenstein JL, et al. Blood. 2006 May 1;107(9):3716-23. doi: 10.1182/blood-2005-03-0897. Epub 2006 Jan 17. Blood. 2006. PMID: 16418334 Free PMC article.

8

Molecular pathogenesis of primary central nervous system lymphoma.

Kadoch C, Treseler P, Rubenstein JL. Kadoch C, et al. Among authors: rubenstein jl. Neurosurg Focus. 2006 Nov 15;21(5):E1. doi: 10.3171/foc.2006.21.5.2. Neurosurg Focus. 2006. PMID: 17134111 Review.

9

Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.

Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M. Rubenstein JL, et al. J Clin Oncol. 2007 Apr 10;25(11):1350-6. doi: 10.1200/JCO.2006.09.7311. Epub 2007 Feb 20. J Clin Oncol. 2007. PMID: 17312328 Clinical Trial.

10

Protein biomarker identification in the CSF of patients with CNS lymphoma.

Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL. Roy S, et al. Among authors: rubenstein jl. J Clin Oncol. 2008 Jan 1;26(1):96-105. doi: 10.1200/JCO.2007.12.1053. Epub 2007 Dec 3. J Clin Oncol. 2008. PMID: 18056677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page